Pennsylvania Medical Marijuana Program: Law, Patients, Access and Oversight
This hub explains how Pennsylvania's medical marijuana program works and how it is overseen. It covers the Medical Marijuana Act (Act 16 of 2016), the Department of Health's Office of Medical Marijuana, patient and caregiver registration, physician certification, qualifying conditions, permitted product forms, and the grower/processor and dispensary permit structure. It also tracks accountability, including the state's first audit of the program, reported by the Pittsburgh Post-Gazette in September 2026. Use it as a starting point for patients, caregivers, clinicians, and industry watchers who want the program's rules, limits, and oversight issues in one place.

Executive summary
Pennsylvania runs one of the largest medical-only cannabis markets in the country under Act 16 of 2016, and its first audit, reported by the Pittsburgh Post-Gazette on September 24, 2026, has put the program's oversight under scrutiny. The Department of Health's Office of Medical Marijuana administers the program under the Medical Marijuana Act (35 P.S. § 10231.101 et seq.). Governor Tom Wolf signed it on April 17, 2016, and the first dispensary opened in Wilkes-Barre in February 2018.
The program certifies patients with qualifying conditions and licenses a capped number of vertically integrated operators. It collects a 5% gross-receipts tax on grower/processor sales. Pennsylvania has not enacted adult-use legalization. Governor Josh Shapiro has pushed for it, and the House has passed legislation, but the Senate has been the obstacle.
The Post-Gazette headline describes the audit as finding "glaring problems." This hub does not restate findings beyond that headline, because the full report should be read in the primary source. It does explain what the program is, who regulates it, where oversight pressure points typically sit, and how an audit could affect operators, patients, and the adult-use debate.
Three questions drive the topic today:
- Can the Department of Health demonstrate adequate control over a roughly $1 billion-a-year market?
- Will legislators fold fixes into an adult-use deal or a standalone reform bill?
- How will federal rescheduling of marijuana to Schedule III, and the end of 280E tax penalties, change operator economics?
Why this matters
A program serving hundreds of thousands of patients and generating about a billion dollars in annual sales cannot be audited once and forgotten; the findings touch patient access, state revenue, and the political case for legalization.
Patients
According to Department of Health reporting in recent years, more than 400,000 Pennsylvanians hold active patient certifications. That is a large share of a state of roughly 13 million people. Patients rely on the program for pain, anxiety, PTSD, cancer symptoms, seizure disorders and other qualifying conditions. Any weakness in the patient registry, product testing, or dispensary compliance reaches them directly.
Operators and investors
Pennsylvania is a limited-license market. The state capped permits at 25 grower/processors and 50 dispensary permittees, plus clinical registrants. Publicly traded multistate operators (MSOs) hold a large share of those licenses. These include Curaleaf, Trulieve, Green Thumb Industries, Verano, Jushi and TerrAscend. Regulatory findings can affect license renewal risk, compliance costs, and valuation of Pennsylvania assets.
Taxpayers and the budget
Act 16 created a Medical Marijuana Program Fund fed by permit fees and the 5% tax on grower/processor gross receipts. The fund pays for administration, patient-assistance programs, research grants and public-safety support. Audit findings about fee collection, tax remittance, or fund use matter to the General Assembly because the same lawmakers are being asked to build a far larger adult-use system.
The legalization debate
Adult-use sales in neighboring New Jersey, New York, Ohio, Maryland and Delaware pull Pennsylvanian dollars across state lines. Opponents of legalization can cite a critical audit as evidence the state is not ready to regulate a bigger market. Supporters can argue the audit shows why a modern statute and funded regulator are overdue.
Background and history
Pennsylvania moved from a prohibition state to a licensed medical market in under two years, but it
Ephrata Borough in Lancaster County welcomed its first medical marijuana dispensary, according to a November 2, 2026 report from WHP Harrisburg. The location operates inside the Pennsylvania Medical Marijuana Program, which the Pennsylvania Department of Health regulates under the Medical Marijuana Act (Act 16 of 2016). The WHP Harrisburg headline did not name the permit holder, the street address, or the first day of sales in the material reviewed for this update. CannIntel will add those details to this hub once they are confirmed against Department of Health permit records and operator announcements. The legal framework for the opening is settled. Governor Tom Wolf signed Act 16 on April 17, 2016, and the Department of Health issues the permits that let a business dispense. Dispensaries may sell only to patients and caregivers registered with the program, and patients need a certification from a practitioner approved by the Department of Health. Act 44 of 2021 amended the original statute. According to the Act, one dispensary permit can cover up to three separate locations, and the Department of Health must approve each location. For patients, a first dispensary inside the borough adds a local access point. The program requires registration, a practitioner certification, and a Medical Marijuana ID card before any purchase, so a new storefront does not change eligibility. It can shorten the trip for registered patients who previously had to go to dispensaries in other communities. For operators and investors, the opening shows that a permitted dispensary can win local acceptance in a smaller Pennsylvania borough, not only in the Philadelphia, Pittsburgh and Harrisburg metro areas. Each new location adds competition for existing Lancaster County permittees and tests demand in a market where the patient base is fixed by the registry. Operators weighing additional sites under their permits should track how the Ephrata store performs once sales data is available. Municipal reception also matters for compliance. A permit from the Department of Health does not replace local zoning approval, so operators need both before opening. Ephrata's public welcome of the dispensary signals a cooperative local process, though the specifics of the borough's approvals were not available in the source report.Update — November 2, 2026: Ephrata Borough gets its first medical marijuana dispensary
Frequently asked questions
What is the Pennsylvania Medical Marijuana Program?
It is the state program created by the Medical Marijuana Act (Act 16 of 2016), signed in April 2016. The Pennsylvania Department of Health administers it through its Office of Medical Marijuana. The program licenses growers/processors and dispensaries, registers patients and caregivers, approves physicians, and sets rules for products. Dispensing to patients began in 2018.
Who regulates medical marijuana in Pennsylvania?
The Pennsylvania Department of Health regulates the program through its Office of Medical Marijuana. It issues permits to growers/processors and dispensaries, approves practitioners, registers patients and caregivers, and sets product and testing requirements. Public audits and legislative oversight also review how well the agency runs the program.
How does a patient qualify for medical marijuana in Pennsylvania?
A patient must have one of the serious medical conditions listed in the law and regulations. They register with the state's Medical Marijuana Program, then get a certification from a physician approved by the Department of Health. After the registration is approved, the patient pays the ID card fee and receives a card to present at dispensaries. Certifications must be renewed periodically.
What conditions qualify for Pennsylvania's program?
Qualifying conditions include cancer, epilepsy, PTSD, Parkinson's disease, multiple sclerosis, glaucoma, and intractable seizures, among others. Severe chronic or intractable pain is also covered. The Department of Health maintains the official list and has expanded it since 2016 on the advice of its advisory board. Check the department's current list before seeking certification.
What forms of cannabis are legal for Pennsylvania patients?
Approved forms include pills, oils, topicals such as gels, creams and ointments, tinctures and liquids, and dry leaf or plant material for vaporization. Direct smoking is not permitted. Edibles were historically restricted, though the law was later changed to allow some forms. Patients should confirm current permitted forms with a dispensary or the Department of Health.
Can Pennsylvania patients grow their own cannabis?
No. The program does not allow home cultivation by patients or caregivers. Cannabis must come from state-permitted grower/processors through licensed dispensaries. Growing at home remains a violation of Pennsylvania law and exposes a person to criminal penalties.
Is recreational marijuana legal in Pennsylvania?
Not under the medical program. Pennsylvania's Medical Marijuana Act covers only certified patients and caregivers. Adult-use sales require separate legislation, and the program does not authorize them. Several neighboring states, including New Jersey, New York, and Maryland, have adult-use markets, so Pennsylvania residents should know the state-line rules.
How many dispensaries and growers does Pennsylvania allow?
Act 16 originally authorized up to 25 grower/processor permits and 50 dispensary permits in the first phase, with each dispensary allowed up to three locations. The law allowed expansion to as many as 50 grower/processors and 150 dispensaries. Later permitting rounds and regulatory changes adjusted the market, so check the Department of Health's current permittee list.
What did Pennsylvania's first audit of the medical marijuana program find?
The Pittsburgh Post-Gazette reported on Sept. 24, 2026 that the state's first audit of the program found "glaring problems." Read the audit itself and the Post-Gazette report for the specific findings, recommendations, and the Department of Health's response. This hub will be updated as officials respond and as any reforms are adopted.
Does a Pennsylvania medical marijuana card protect patients under federal law?
No. Cannabis remains a federally controlled substance, so a state card gives protection only under Pennsylvania law. Federal rules can still affect firearm purchases, federal employment, and federally regulated jobs and housing. The law also bars driving while impaired. Patients should talk to their physician or an attorney about their own circumstances.
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.